Consenso latinoamericano de diagnóstico de la enfermedad por reflujo gastroesofágico
DOI:
https://doi.org/10.52787/agl.v52i2.210Palabras clave:
Enfermedad por reflujo gastroesofágico, monitoreo ambulatorio de reflujoResumen
La enfermedad por reflujo gastroesofágico (ERGE) es sumamente prevalente en nuestro medio. Sus síntomas son variados y los mecanismos fisiopatológicos son múltiples. Por lo tanto, el diagnóstico de esta entidad suele ser complejo. Han sido descriptos una serie de métodos diagnósticos. No obstante, el patrón de oro continúa siendo el tiempo de exposición ácida, medido durante el monitoreo ambulatorio de reflujo a través de pH-metría. El objetivo de este primer consenso latinoamericano fue evaluar críticamente, sobre la base de las mejores evidencias disponibles a la fecha, los diferentes métodos diagnósticos propuestos para la ERGE y emitir recomendaciones consensuadas luego de la discusión entre un grupo de expertos y una votación. Este consenso fue desarrollado por un grupo de expertos a partir de una búsqueda sistemática de la literatura y utilizando la metodología GRADE (Grading of Recommendations Assessment, Development and Evaluation) para la evaluación de la calidad de la evidencia y la decisión de la fuerza de recomendación. Se emitieron recomendaciones en cuanto a la utilidad de diferentes métodos diagnósticos en relación con la ERGE.
Citas
-1. Chiocca JC, Olmos JA, Salis GB, Soifer LO, Higa R, Marcolongo M, et al. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population based study. Aliment Pharmacol Ther. 2005;22(4):331-42.
-2. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871-80.
-3. Páramo-Hernández DB, Albis R, Galiano MT, de Molano B, Rincón R, Pineda-Ovalle LF, et al. Prevalencia de síntomas del reflujo gastroesofágico y factores asociados: una encuesta poblacional en las principales ciudades de Colombia. Revista colombiana de Gastroenterología. 2016;31(4):337-46.
-4. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, the Global Consensus Group. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus [Internet]. The American Journal of Gastroenterology. 2006;101:1900-20. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2006.00630.x
-5. Zerbib F, Bredenoord AJ, Fass R, Kahrilas PJ, Roman S, Savarino E, et al. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease. Neurogastroenterol Motil. 2021;33(4):e14075.
-6. Yadlapati R, Gyawali CP, Pandolfino JE. Personalized Approach to the Evaluation and Management of Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol [Internet]. 2022 Feb 2. Disponible en: http://dx.doi.org/10.1016/j.cgh.2022.01.025
-7. Hoff DAL, McMahon B, Gregersen H. Esophageal multimodal stimulation and sensation [Internet]. Annals of the New York Academy of Sciences. 2018;1434:210-8. Disponible en: http://dx.doi.org/10.1111/nyas.13730
-8. Ustaoglu A, Woodland P. Esophageal afferent innervation and its role in gastro-esophageal reflux disease symptoms. Curr Opin Gastroenterol. 2021;37(4):372-7.
-9. Lacy BE, Weiser K, Chertoff J, Fass R, Pandolfino JE, Richter JE, et al. The Diagnosis of Gastroesophageal Reflux Disease [Internet]. The American Journal of Medicine. 2010;123:583-92. Disponible en: http://dx.doi.org/10.1016/j.amjmed.2010.01.007
-10. Wiener GJ, Morgan TM, Copper JB, Castell DO, Sinclair JW, Richter JE. Ambulatory 24-hour esophageal pH monitoring. Dig Dis Sci. 1988;33(9):1127-33.
-11. de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil. 2014;26(1):28-35.
-12. Wang AJ, Wang H, Xu L, Lv NH, He XX, Hong JB, et al. Predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease. Dig Liver Dis. 2013;45(4):296-300.
-13. Ribolsi M, Savarino E, De Bortoli N, Balestrieri P, Furnari M, Martinucci I, et al. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther. 2014;40(8):966-73.
-14. Francis DO, Goutte M, Slaughter JC, Garrett CG, Hagaman D, Holzman MD, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011;121(9):1902-9.
-15. Patel A, Sayuk GS, Gyawali CP. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol. 2014;109(6):836-44.
-16. Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015;13(5):884-91.
-17. Gyawali CP, Prakash Gyawali C, Kahrilas PJ, Savarino E, Zerbib F, Mion F, et al. Modern diagnosis of GERD: the Lyon Consensus [Internet]. Gut. 2018;67:1351-62. Disponible en: http://dx.doi.org/10.1136/gutjnl-2017-314722
-18. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
-19. Collaboration C. Review Manager (RevMan) [Computer Program] Version 5.2. 3, The Nordic Cochrane Centre, Copenhagen, 2012. Health Psychol Rev. 2014;17.
-20. GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Disponible en:gradepro. org.: Evidence Prime. Inc;
-21. Ciapponi A. QUADAS-2: instrumento para la evaluación de la calidad de estudios de precisión diagnóstica. Evidencia, actualización en la práctica ambulatoria [Internet]. 2015;18(1). Disponible en: https://www.evidencia.org/index.php/Evidencia/article/view/6341
-22. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement [Internet]. PLoS Medicine. 2009;6:e1000097. Disponible en: http://dx.doi.org/10.1371/journal.pmed.1000097
-23. Blokdyk G. Zoom Software a Complete Guide - 2020 Edition. Emereo Pty Limited; 2020. 306 p.
-24. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux
disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140(7):518-27.
-25. Jonasson C, Wernersson B, Hoff DAL, Hatlebakk JG. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2013;37(5):564-72.
-26. Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010;59(6):714-21.
-27. Bai Y, Du Y, Zou D, Jin Z, Zhan X, Li ZS, et al. Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients. J Gastroenterol Hepatol. 2013;28(4):626-31.
-28. Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care [Internet]. Alimentary Pharmacology & Therapeutics. 2009;30:1030-8. Disponible en: http://dx.doi.org/10.1111/j.1365-2036.2009.04142.x
-29. Lacy BE, Chehade R, Crowell MD. A Prospective Study to Compare a Symptom-Based Reflux Disease Questionnaire to 48-h Wireless pH Monitoring for the Identification of Gastroesophageal Reflux (revised 2-26-11) [Internet]. American Journal of Gastroenterology. 2011;106:1604-11. Disponible en: http://dx.doi.org/10.1038/ajg.2011.180
-30. Suzuki H, Matsuzaki J, Okada S, Hirata K, Fukuhara S, Hibi T. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan. United European Gastroenterol J. 2013;1(3):175-83.
-31. Zaika S, Paliy I, Chernobrovyi V, Ksenchyn OO. The study and comparative analysis of GerdQ and GSRS Questionnaires on gastroesophageal reflux disease diagnostics. Prz Gastroenterol. 2020;15(4):323-9.
-32. Zavala-Gonzales MA, Azamar-Jacome AA, Meixueiro-Daza A, de la Medina AR, Job RHJ, Roesch-Dietlen F, et al. Validation and Diagnostic Usefulness of Gastroesophageal Reflux Disease Questionnaire in a Primary Care Level in Mexico [Internet]. Journal of Neurogastroenterology and Motility. 2014;20:475-82. Disponible en: http://dx.doi.org/10.5056/jnm14014
-33. Zhou LY, Wang Y, Lu JJ, Lin L, Cui RL, Zhang HJ, et al. Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology [Internet]. Journal of Digestive Diseases. 2014;15:230-8. Disponible en: http://dx.doi.org/10.1111/1751-2980.12135
-34. Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154(2):302-18.
-35. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001;120(7):1599-606.
-36. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135(4):1383-91, 1391.e1-5.
-37. Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999;159(18):2161-8.
-38. Weijenborg PW, Cremonini F, Smout AJP, Bredenoord AJ. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis [Internet]. Neurogastroenterology & Motility. 2012;24:747-e350. Disponible en: http://dx.doi.org/10.1111/j.1365-2982.2012.01888.x
-39. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007;(2):CD003244.
-40. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112(6):1798-810.
-41. Sabesin SM, Berlin RG, Humphries TJ, Bradstreet DC, Walton- Bowen KL, Zaidi S. Famotidine Relieves Symptoms of Gastroesophageal Reflux Disease and Heals Erosions and Ulcerations: Results of a Multicenter, Placebo-Controlled, Dose-Ranging Study. Arch Intern Med. 1991;151(12):2394-400.
-42. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2(8):656-64.
-43. Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease [Internet]. Cochrane Database of Systematic Reviews. 2013. Disponible en: http://dx.doi.org/10.1002/14651858.cd002095.pub5
-44. Boeckxstaens G, El-Serag HB, Smout AJP, Kahrilas PJ. Symptomatic reflux disease: the present, the past and the future [Internet]. Gut. 2014;63:1185-93. Disponible en: http://dx.doi.org/10.1136/gutjnl-2013-306393
-45. Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106(8):1419-25; quiz 1426.
-46. Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2012;10(6):612-9.
-47. Aanen MC, Weusten BLA, Numans ME, de Wit NJ, Baron A, Smout AJP. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care [Internet]. Alimentary Pharmacology and Therapeutics. 2006;24:1377-84. Disponible en: http://dx.doi.org/10.1111/j.1365-2036.2006.03121.x
-48. Fass R, Achem SR. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil. 2011;17(2):110-23.
-49. Park SH, Choi JY, Park EJ, Lee JJ, Lee S, Na JO, et al. Prevalence of Gastrointestinal Diseases and Treatment Status in Noncardiac Chest Pain Patients. Korean Circ J. 2015;45(6):469-72.
-50. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial [Internet]. Alimentary Pharmacology & Therapeutics. 2004;19:1123-30. Disponible en: http://dx.doi.org/10.1111/j.1365-2036.2004.01941.x
-51. Dekel R, Martinez-Hawthorne SD, Guillen RJ, Fass R. Evaluation of symptom index in identifying gastroesophageal reflux
disease-related noncardiac chest pain. J Clin Gastroenterol. 2004;38(1):24-9.
-52. Dickman R, Emmons S, Cui H, Sewell J, Hernandez D, Esquivel RF, et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial [Internet]. Alimentary Pharmacology and Therapeutics. 2005;22:547-55. Disponible en: http://dx.doi.org/10.1111/j.1365-2036.2005.02620.x
-53. Fass R, Brian Fennerty M, Ofman JJ, Gralnek IM, Johnson C, Camargo E, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain [Internet]. Gastroenterology. 1998;115:42-9. Disponible en: http://dx.doi.org/10.1016/s0016-5085(98)70363-4
-54. Kim BJ, Choi SC, Kim JJ, Rhee JC, Rhee PL. Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain [Internet]. Journal of Gastroenterology and Hepatology. 2010;25:1855-60. Disponible en: http://dx.doi.org/10.1111/j.1440-1746.2010.06415.x
-55. Kim JH, Sinn DH, Son HJ, Kim JJ, Rhee JC, Rhee PL. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. J Gastroenterol Hepatol. 2009;24(9):1504-9.
-56. Ko SY, Kim SI, Kim JH, Lee JH, Lee KJ, Hong SN, et al. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain. J Gastroenterol Hepatol. 2012;27(9):1484-9.
-57. Mohd H, Qua CS, Wong CH, Azman W, Goh KL. Non-cardiac chest pain: Prevalence of reflux disease and response to acid suppression in an Asian population [Internet]. Journal of Gastroenterology and Hepatology. 2009;24:288-93. Disponible en: http://dx.doi.org/10.1111/j.1440-1746.2008.05702.x
-58. Pandak WM, Arezo S, Everett S, Jesse R, DeCosta G, Crofts T, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 2002;35(4):307-14.
-59. Xia HHX, Lai KC, Lam SK, Hu WHC, Wong NYH, Hui WM, et al. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther. 2003;17(3):369-77.
-60. Wertli MM, Ruchti KB, Steurer J, Held U. Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis. BMC Med. 2013;11:239.
-61. Williams JF, Sontag SJ, Schnell T, Leya J. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease. Am J Gastroenterol. 2009;104(9):2145-52.
-62. Kushnir VM, Sayuk GS, Gyawali CP. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain. Am J Gastroenterol. 2010;105(5):1032-8.
-63. George N, Abdallah J, Maradey-Romero C, Gerson L, Fass R. Review article: the current treatment of non-cardiac chest pain [Internet]. Alimentary Pharmacology & Therapeutics. 2016;43:213-39. Disponible en: http://dx.doi.org/10.1111/apt.13458
-64. O’Hara J, Stocken DD, Watson GC, Fouweather T, McGlashan J, MacKenzie K, et al. Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial [Internet]. BMJ. 2021. P. m4903. Disponible en: http://dx.doi.org/10.1136/bmj.m4903
-65. Vaezi MF, Katzka D, Zerbib F. Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now? Clin Gastroenterol Hepatol. 2018;16(7):1018-29.
-66. Francis DO, Rymer JA, Slaughter JC, Choksi Y, Jiramongkolchai P, Ogbeide E, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108(6):905-11.
-67. Metz D, Childs M, Ruiz C, Weinstein G. Pilot study of the oral omeprazole test for reflux laryngitis [Internet]. Otolaryngology - Head and Neck Surgery. 1997;116:41-6. Disponible en: https://journals.sagepub.com/doi/full/10.1016/S0194-59989770350-4
-68. Siupsinskiene N, Adamonis K. Diagnostic test with omeprazole in patients with posterior laryngitis. Medicina. 2003;39(1):47-55.
-69. Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, et al. Laryngopharyngeal Reflux: Prospective Cohort Study Evaluating Optimal Dose of Proton-Pump Inhibitor Therapy and Pretherapy Predictors of Response [Internet]. The Laryngoscope. 2005;115:1230-8. Disponible en: http://dx.doi.org/10.1097/01.mlg.0000163746.81766.45
-70. Šiupšinskienè N, Adamonis K. Diagnostic test with omeprazole in patients with posterior laryngitis. Medicina. 2003;39(1):47-55.
-71. Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 200615;173(10):1091-7.
-72. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 20221;117(1):27-56.
-73. de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol. 2012;18(32):4363-70.
-74. Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, et al. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51(6):467-78.
-75. Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil. 2021;33(1):e14058.
-76. Johnston BT, Troshinsky MB, Castell JA, Castell DO. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol. 1996;91(6):1181-5.
-77. Serna-Gallegos D, Basseri B, Bairamian V, Pimentel M, Soukiasian HJ. Gastroesophageal reflux reported on esophagram does not correlate with pH monitoring and high-resolution esophageal manometry. Am Surg. 2014;80(10):1026-9.
-78. Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol. 2001;96(6):1711-7.
-79. Kahrilas PJ. The role of hiatus hernia in GERD. Yale J Biol Med. 1999;72(2-3):101-11.
-80. Hill LD, Kozarek RA, Kraemer SJM, Aye RW, Dale Mercer C, Low DE, et al. The gastroesophageal flap valve: in vitro and in vivo observations [Internet]. Gastrointestinal Endoscopy. 1996;44:541-7. Disponible en: http://dx.doi.org/10.1016/s0016-5107(96)70006-8
-81. Hill LD, Kozarek RA. The Gastroesophageal Flap Valve [Internet]. Journal of Clinical Gastroenterology. 1999;28:194-7. Disponible en: http://dx.doi.org/10.1097/00004836-199904000-00002
-82. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol. 1987;22(6):714-8.
-83. Kim GH, Song GA, Kim TO, Jo HJ, Kim DH, Heo J, et al. Endoscopic grading of gastroesophageal flap valve and atrophic gastritis is helpful to predict gastroesophageal reflux. J Gastroenterol Hepatol. 2008;23(2):208-14.
-84. Lin BR, Wong JM, Chang MC, Liao CC, Yang PM, Jeng JH, et al. Abnormal gastroesophageal flap valve is highly associated with gastroesophageal reflux disease among subjects undergoing routine endoscopy in Taiwan. J Gastroenterol Hepatol. 2006;21(3):556-62.
-85. Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med. 1999;72(2-3):93-100.
-86. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172-80.
-87. Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29(10):e13067.
-88. Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10(6):371-80.
-89. Poh CH, Gasiorowska A, Navarro-Rodríguez T, Willis MR, Hargadon D, Noelck N, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71(1):28-34.
-90. Akdamar K, Ertan A, Agrawal NM, McMahon FG, Ryan J. Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc. 1986;32(2):78-80.
-91. Takashima T, Iwakiri R, Sakata Y, Yamaguchi D, Tsuruoka N, Akutagawa K, et al. Endoscopic reflux esophagitis and Helicobacter pylori infection in young healthy Japanese volunteers. Digestion. 201220;86(1):55-8.
-92. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano- Monghidoro study. Gut. 2008;57(10):1354-9.
-93. Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, et al. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg. 2013;217(4):586-97.
-94. Book DT, Rhee JS, Toohill RJ, Smith TL. Perspectives in laryngopharyngeal reflux: an international survey. Laryngoscope [Internet]. 2002. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1097/00005537-200208000-00014?casa_token=15hl6yJMjvoAAAAA:bZBu-XfNXXrP9ofjyiRNOEB17VTIyVs4Q0ehranWLCGp4aOJMjHFYYhqGNbd_btkZs-K3StInD_ecJEk
-95. Reulbach TR, Belafsky PC, Blalock PD, Koufman JA, Postma GN. Occult laryngeal pathology in a community-based cohort. Otolaryngol Head Neck Surg. 2001;124(4):448-50.
-96. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology- Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;127(1):32-5.
-97. Altman KW, Stephens RM, Lyttle CS, Weiss KB. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope. 2005;115(7):1145-53.
-98. Francis DO, Vaezi MF. Should the Reflex Be Reflux? Throat Symptoms and Alternative Explanations. Clin Gastroenterol Hepatol. 2015;13(9):1560-6.
-99. Barrett CM, Patel D, Vaezi MF. Laryngopharyngeal Reflux and Atypical Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am. 2020;30(2):361-76.
-100. Barry DW, Vaezi MF. Laryngopharyngeal reflux: More questions than answers. Cleve Clin J Med. 2010;77(5):327-34.
-101. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001;111(8):1313-7.
-102. Dhillon VK, Akst LM. How to Approach Laryngopharyngeal Reflux: An Otolaryngology Perspective. Curr Gastroenterol Rep. 2016;18(8):44.
-103. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1(5):333-44.
-104. Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope. 2002;112(6):1019-24.
-105. Chang BA, Danielle MacNeil S, Morrison MD, Lee PK. The Reliability of the Reflux Finding Score Among General Otolaryngologists [Internet]. Journal of Voice. 2015;29:572-7. Disponible en: http://dx.doi.org/10.1016/j.jvoice.2014.10.009
-106. Hicks DM, Ours TM, Abelson TI, Vaezi MF, Richter JE. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice. 2002;16(4):564-79.
-107. Milstein CF, Charbel S, Hicks DM, Abelson TI, Richter JE, Vaezi MF. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope. 2005;115(12):2256-61.
-108. Swoger J, Ponsky J, Hicks DM, Richter JE, Abelson TI, Milstein C, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol. 2006;4(4):433-41.
-109. Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101(11):2646-54.
-110. Herbella FAM, Andolfi C, Vigneswaran Y, Patti MG, Pinna BR. Importance of esophageal manometry and pH monitoring for the evaluation of otorhinolaryngologic (ENT) manifestations of GERD. A multicenter study. J Gastrointest Surg. 2016;20(10):1673-8.
-111. Woo P, Noordzij P, Ross JA. Association of esophageal reflux and globus symptom: comparison of laryngoscopy and 24-hour pH manometry. Otolaryngol Head Neck Surg. 1996;115(6):502-7.
-112. Fass R, Ofman JJ. Gastroesophageal reflux disease-should we adopt a new conceptual framework? Am J Gastroenterol. 2002;97(8):1901-9.
-113. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40(3):275-85.
-114. Sharma P, Wani S, Bansal A, Hall S, Puli S, Mathur S, et al. A Feasibility Trial of Narrow Band Imaging Endoscopy in Patients with Gastroesophageal Reflux Disease [Internet]. Gastroenterology. 2007;133:454-64. Disponible en: http://dx.doi.org/10.1053/j.gastro.2007.06.006
-115. Rey JW, Deris N, Marquardt JU, Thomaidis T, Moehler M, Kittner JM, et al. High-definition endoscopy with iScan and Lugol’s solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group [Internet]. Diseases of the Esophagus. 2016;29:185-1. Disponible en: http://dx.doi.org/10.1111/dote.12308
-116. Wong WM, Bautista J, Dekel R, Malagon IB, Tuchinsky I, Green C, et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trial. Aliment Pharmacol Ther. 2005;21(2):155-63.
-117. Fass R, Hell R, Sampliner RE, Pulliam G, Graver E, Hartz V, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci. 1999;44(11):2263-9.
-118. Sweis R, Fox M, Anggiansah R, Anggiansah A, Basavaraju K, Canavan R, et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther. 2009;29(6):669-76.
-119. Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58(2):163-74.
-120. Savarino E, Zentilin P, Mastracci L, Dulbecco P, Marabotto E, Gemignani L, et al. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol. 2013;48(4):473-82.
-121. Kandulski A, Jechorek D, Caro C, Weigt J, Wex T, Mönkemüller K, et al. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Aliment Pharmacol Ther. 2013;38(6):643-51.
-122. Mastracci L, Spaggiari P, Grillo F, Zentilin P, Dulbecco P, Ceppa P, et al. Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations. Virchows Arch. 2009;454(1):31-9.
-123. Cui R, Zhang H, Zhou L, Lu J, Xue Y, Wang Y, et al. Diagnostic value of dilated intercellular space and histopathologic scores in gastroesophageal reflux disease. Dis Esophagus. 2015;28(6):530-7.
-124. Bowrey DJ, Williams GT, Clark GWB. Histological changes in the oesophageal squamous mucosa: correlation with ambulatory 24 hour pH monitoring. J Clin Pathol. 2003;56(3):205-8.
-125. Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, et al. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol. 2010;41(2):223-31.
-126. Schneider NI, Plieschnegger W, Geppert M, Wigginghaus B, Hoess GM, Eherer A, et al. Validation study of the Esohisto consensus guidelines for the recognition of microscopic esophagitis (histoGERD Trial). Hum Pathol. 2014;45(5):994-1002.
-127. Zentilin P, Savarino V, Mastracci L, Spaggiari P, Dulbecco P, Ceppa P, et al. Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group [Internet]. The American Journal of Gastroenterology. 2005;100:2299-306. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2005.50209.x
-128. Edebo A, Vieth M, Tam W, Bruno M, van Berkel AM, Stolte M, et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus. 2007;20(3):232-8.
-129. Caviglia R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MPL, et al. Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol. 2005;100(3):543-8.
-130. Caviglia R, Ribolsi M, Gentile M, Rabitti C, Emerenziani S, Guarino MPL, et al. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;25(5):629-36.
-131. Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic Esophagitis [Internet]. American Journal of Clinical Pathology. 2008;130:508-13. Disponible en: http://dx.doi.org/10.1309/d3pcf6d6yymqrx9a
-132. Katzka DA, Ravi K, Geno DM, Smyrk TC, Iyer PG, Alexander JA, et al. Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis [Internet]. Clinical Gastroenterology and Hepatology. 2015;13:1242-8.e1. Disponible en: http://dx.doi.org/10.1016/j.cgh.2014.12.032
-133. Takubo K, Honma N, Aryal G, Sawabe M, Arai T, Tanaka Y, et al. Is There a Set of Histologic Changes That Are Invariably Reflux Associated? [Internet]. Archives of Pathology & Laboratory Medicine. 2005;129:159-63. Disponible en: http://dx.doi.org/10.5858/2005-129-159-itasoh
-134. Demir D, Doğanavşargil B, Sarsık B, Sezak M, Tunçyürek M. Is it possible to diagnose infectious oesophagitis without seeing the causative organism? A histopathological study. Turk J Gastroenterol. 2014;25(5):481-7.
-135. Blevins CH, Dierkhising RA, Geno DM, Johnson ML, Vela MF, Ravi K, et al. Obesity and GERD impair esophageal epithelial permeability through 2 distinct mechanisms. Neurogastroenterol Motil. 2018;30(10):e13403.
-136. Farré R, De Vos R, Geboes K, Verbecke K, Vanden Berghe P, Depoortere I, et al. Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut. 2007;56(9):1191-7.
-137. Bove M, Vieth M, Dombrowski F, Ny L, Ruth M, Lundell L. Acid Challenge to the Human Esophageal Mucosa: Effects on Epithelial Architecture in Health and Disease [Internet]. Digestive Diseases and Sciences. 2005;50:1488-96. Disponible en: http://dx.doi.org/10.1007/s10620-005-2867-3
-138. Katz PO, Gerson LB, Vela MF. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease [Internet]. American Journal of Gastroenterology. 2013;108:308-28. Disponible en: http://dx.doi.org/10.1038/ajg.2012.444
-139. Chae S, Richter JE. Wireless 24, 48, and 96 Hour or Impedance or Oropharyngeal Prolonged pH Monitoring: Which Test, When, and Why for GERD? [Internet]. Current Gastroenterology Reports. 2018;20. Disponible en: http://dx.doi.org/10.1007/s11894-018-0659-0
-140. Kessels SJM, Newton SS, Morona JK, Merlin TL. Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease: A Systematic Review. J Clin Gastroenterol. 2017;51(9):777-88.
-141. Andrews CN, Sadowski DC, Lazarescu A, Williams C, Neshev E, Storr M, et al. Unsedated peroral wireless pH capsule placement vs. standard pH testing: a randomized study and cost analysis. BMC Gastroenterol. 2012;12:58.
-142. Wenner J, Johnsson F, Johansson J, Öberg S. Wireless Esophageal pH Monitoring Is Better Tolerated than the Catheter-Based Technique: Results from a Randomized Cross-Over Trial [Internet]. The American Journal of Gastroenterology. 2007;102:239-45. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2006.00939.x
-143. Grigolon A, Bravi I, Cantù P, Conte D, Penagini R. Wireless pH monitoring: Better tolerability and lower impact on daily habits [Internet]. Digestive and Liver Disease. 2007;39:720-4. Disponible en: http://dx.doi.org/10.1016/j.dld.2007.05.011
-144. Bradley AG, Crowell MD, DiBaise JK, Kim HJ, Burdick GE, Fleischer DE, et al. Comparison of the impact of wireless versus catheter-based pH-metry on daily activities and study-related symptoms. J Clin Gastroenterol. 2011;45(2):100-6.
-145. Schneider JH, Kramer KM, Königsrainer A, Granderath FA. Ambulatory pH: monitoring with a wireless system [Internet]. Surgical Endoscopy. 2007;21:2076-80. Disponible en: http://dx.doi.org/10.1007/s00464-007-9301-1
-146. Croffie JM, Fitzgerald JF, Molleston JP, Gupta SK, Corkins MR, Pfefferkorn MD, et al. Accuracy and Tolerability of the Bravo Catheter-free pH Capsule in Patients Between the Ages of 4 and 18 Years [Internet]. Journal of Pediatric Gastroenterology & Nutrition. 2007;45:559-63. Disponible en: http://dx.doi.org/10.1097/mpg.0b013e3180dc9349
-147. Azzam RS, Sallum RAA, Brandão JF, Navarro-Rodriguez T, Nasi A. Comparative study of two modes of gastroesophageal reflux measuring: conventional esophageal pH monitoring and wireless pH monitoring [Internet]. Arquivos de Gastroenterologia. 2012;107-12. Disponible en: http://dx.doi.org/10.1590/s0004-28032012000200003
-148. Varannes SBD, des Varannes SB. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo) [Internet]. Gut. 2005;54:1682-6. Disponible en: http://dx.doi.org/10.1136/gut.2005.066274
-149. Håkanson BS, Berggren P, Granqvist S, Ljungqvist O, Thorell A. Comparison of wireless 48-h (Bravo) versus traditional ambulator 24-h esophageal pH monitoring [Internet]. Scandinavian Journal of Gastroenterology. 2009;44:276-83. Disponible en: http://dx.doi.org/10.1080/00365520802588109
-150. Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system [Internet]. The American Journal of Gastroenterology. 2003;98:740-9. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2003.07398.x
-151. Wenner J, Hall M, Höglund P, Johansson J, Johnsson F, Öberg S. Wireless pH Recording Immediately Above the Squamocolumnar Junction Improves the Diagnostic Performance of Esophageal pH Studies [Internet]. The American Journal of Gastroenterology. 2008;103:2977-85. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2008.02174.x
-152. Bansal A, Wani S, Rastogi A, Rastogi K, Goyal A, Hall S, et al. Impact of Measurement of Esophageal Acid Exposure Close to the Gastroesophageal Junction on Diagnostic Accuracy and Event-Symptom Correlation [Internet]. American Journal of Gastroenterology. 2009;104:2918-25. Disponible en: http://dx-.doi.org/10.1038/ajg.2009.506
-153. Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, et al. Bravo Catheter-Free pH Monitoring: Normal Values, Concordance, Optimal Diagnostic Thresholds, and Accuracy [Internet]. Clinical Gastroenterology and Hepatology. 2009;7:60-7. Disponible en: http://dx.doi.org/10.1016/j.cgh.2008.08.020
-154. Yang XJ, Gan T, Wang L, Liao Z, Tao XH, Shen W, et al. Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study. World J Gastroenterol. 201428;20(40):14865-74.
-155. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease [Internet]. Clinical Gastroenterology and Hepatology. 2005;3:329-34. Disponible en: http://dx.doi.org/10.1016/s1542-3565(05)00021-2
-156. Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M. The Impact of Prolonged pH Measurements on the Diagnosis of Gastroesophageal Reflux Disease: 4-Day Wireless pH Studies [Internet]. The American Journal of Gastroenterology. 2007;102:2642-7. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2007.01461.x
-157. Patel R, Kumar A, Jacobs JW, Chae S, Richter JE. Su1096 - 96-Hour Esophageal PH Monitoring: The Tiebreaker for Abnormal Demeester Score and Symptom Index [Internet]. Gastroenterology. 2018;154:S-486. Disponible en: http://dx.doi.org/10.1016/s0016-5085(18)31852-3
-158. Garrean CP, Zhang Q, Gonsalves N, Hirano I. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. Am J Gastroenterol. 2008l;103(7):1631-7.
-159. Roman S, Bruley des Varannes S, Pouderoux P, Chaput U, Mion F, Galmiche JP, et al. Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil. 2006;18(11):978-86.
-160. Masiak W, Wallner G, Wallner J, Pedowski T, Solecki M. Combined Esophageal Multichannel Intraluminal Impedance and pH Monitoring (MII -pH) in the Diagnostics and Treatment of Gastroesophageal Reflux Disease and its Complications [Internet]. Polish Journal of Surgery. 2011;83. Disponible en: http://dx.doi.org/10.2478/v10035-011-0076-7
-161. Zerbib F, Belhocine K, Simon M, Capdepont M, Mion F, Bruley des Varannes S, et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut. 2012;61(4):501-6.
-162. Bell R, Lipham J, Louie BE, Williams V, Luketich JD. Randomized controlled trial of Magnetic Sphincter Augmentation (MSA) vs. omeprazole in gerd patients with regurgitation: initial results from the caliber trial. Gastroenterology. 2017;152(5):S1309.
-163. Rogers BD, Valdovinos LR, Crowell MD, Bell R, Vela MF, Gyawali CP. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation. Gut. 2021;70(3):450-5.
-164. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med. 1984;310(5):284-8.
-165. Frazzoni M, Bertani H, Manta R, Mirante VG, Frazzoni L, Conigliaro R, et al. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis [Internet]. Digestive and Liver Disease. 2014;46:596-602. Disponible en: http://dx.doi.org/10.1016/j.dld.2014.03.005
-166. Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil [Internet]. 2017;29(11). Disponible en: http://dx.doi.org/10.1111/nmo.13116
-167. Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease - a 24-h impedance-pH monitoring assessment [Internet]. Neurogastroenterology & Motility. 2013;25:399-e295. Disponible en: http://dx.doi.org/10.1111/nmo.12080
-168. Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Furnari M, Martinucci I, et al. The added diagnostic value of postreflux swallow induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil [Internet]. 2017;29(3). Disponible en: http://dx.doi.org/10.1111/nmo.12947
-169. Sun YM, Gao Y, Gao F. Role of Esophageal Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Discriminating Chinese Patients With Heartburn. J Neurogastroenterol Motil. 2019;25(4):515-20.
-170. Ribolsi M, Frazzoni M, Marabotto E, De Carlo G, Ziola S, Maniero D, et al. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus. Aliment Pharmacol Ther. 2021;54(4):412-8.
-171. Gyawali CP, Prakash Gyawali C, Tutuian R, Zerbib F, Rogers BD, Frazzoni M, et al. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management [Internet]. Gastroenterology. 2021;161:1412-22. Disponible en: http://dx.doi.org/10.1053/j.gastro.2021.07.004
-172. Farre R, Blondeau K, Clement D, Vicario M, Cardozo L, Vieth M, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique [Internet]. Gut. 2011;60:885-92. Disponible en: http://dx.doi.org/10.1136/gut.2010.233049
-173. Kessing BF, Bredenoord AJ, Weijenborg PW, Hemmink GJM, Loots CM, Smout AJPM. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol. 2011;106(12):2093-7.
-174. Saritas Yuksel E, Higginbotham T, Slaughter JC, Mabary J, Kavitt RT, Garrett CG, et al. Use of direct, endoscopic-guided measurements of mucosal impedance in diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2012;10(10):1110-6.
-175. Ates F, Yuksel ES, Higginbotham T, Slaughter JC, Mabary J, Kavitt RT, et al. Mucosal Impedance Discriminates GERD From Non-GERD Conditions [Internet]. Gastroenterology. 2015;148:334-43. Disponible en: http://dx.doi.org/10.1053/j.gastro.2014.10.010
-176. Patel DA, Higginbotham T, Slaughter JC, Aslam M, Yuksel E, Katzka D, et al. Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders [Internet]. Gastroenterology. 2019;156:1617-26.e1. Disponible en: http://dx.doi.org/10.1053/j.gastro.2019.01.253
-177. Martinucci I, de Bortoli N, Savarino E, Piaggi P, Bellini M, Antonelli A, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn [Internet]. Neurogastroenterology & Motility. 2014;26:546-55. Disponible en: http://dx.doi.org/10.1111/nmo.12299
-178. Kandulski A, Weigt J, Caro C, Jechorek D, Wex T, Malfertheiner P. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. Clin Gastroenterol Hepatol. 2015;13(6):1075-81.
-179. Hoshikawa Y, Sawada A, Sonmez S, Nikaki K, Woodland P, Yazaki E, et al. Measurement of Esophageal Nocturnal Baseline Impedance: A Simplified Method [Internet]. Journal of Neurogastroenterology and Motility. 2020;26:241-7. Disponible en: http://dx.doi.org/10.5056/jnm19183
-180. Pineda-Ovalle LF, Galindo-M P, Borráez-Segura BA, Guio A, Angarita-Santos O, Arbeláez-Méndez VH, et al. Eficacia diagnóstica de la impedancia basal nocturna media, un nuevo parámetro para el estudio de la enfermedad por reflujo gastroesofágico [Internet]. Revista Colombiana de Gastroenterología. 2018;33:211. Disponible en: http://dx.doi.org/10.22516/25007440.287
-181. van Rhijn BD, Weijenborg PW, Verheij J, van den Bergh Weerman MA, Verseijden C, van den Wijngaard RMJGJ, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12(11):1815-23.e2.
-182. Rengarajan A, Savarino E, Della Coletta M, Ghisa M, Patel A, Gyawali CP. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring. Clin Gastroenterol Hepatol. 2020;18(3):589-95.
-183. Patel A, Wang D, Sainani N, Sayuk GS, Gyawali CP. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2016;44(8):890-8.
-184. Sifrim D, Roman S, Savarino E, Bor S, Bredenoord AJ, Castell D, et al. Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world. Gut [Internet]. 2020. Disponible en: http://dx.doi.org/10.1136/gutjnl-2020-322627
-185. Bortoli N de, de Bortoli N, Martinucci I, Savarino E, Tutuian R, Frazzoni M, et al. Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn [Internet]. Clinical Gastroenterology and Hepatology. 2015;13:1082 -8.e1. Disponible en: http://dx.doi.org/10.1016/j.cgh.2014.11.035
-186. Triggs JR, Kahrilas PJ. Editorial: symptom association probability during reflux testing-what is the gain? Aliment Pharmacol Ther. Wiley; 2018;47(9):1317-8.
-187. Bredenoord AJ, Weusten BLAM, Smout AJPM. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut. 2005;54(12):1810-7. 188. Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional Esophageal Disorders. Gastroenterology [Internet]. 2016. Disponible en: http://dx.doi.org/10.1053/j.gastro.2016.02.012
-189. Scarpellini E, Ang D, Pauwels A, De Santis A, Vanuytsel T, Tack J. Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol. 2016;13(5):281-94.
-190. Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154(2):277-88.
-191. Lam HG, Breumelhof R, Roelofs JM, Van Berge Henegouwen GP, Smout AJ. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci. 1994;39(2):402-9.
-192. Herregods TVK, Pauwels A, Tack J, Smout AJPM, Bredenoord AJ. Reflux-cough syndrome: Assessment of temporal association between reflux episodes and cough bursts. Neurogastroenterol Motil [Internet]. 2017;29(12). Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/nmo.13129193. Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83(4):358-61.
-194. Singh S, Richter JE, Bradley LA, Haile JM. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993;38(8):1402-8.
-195. Ghillebert G, Janssens J, Vantrappen G, Nevens F, Piessens J. Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut. 1990;31(7):738-44.
-196. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology. 1994;107(6):1741-5.
-197. Gaddam S, Wani S, Ahmed H, Maddur P, Hall SB, Gupta N, et al. The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis. Aliment Pharmacol Ther. 2010;32(10):1266-74.
-198. Kushnir VM, Sathyamurthy A, Drapekin J, Gaddam S, Sayuk GS, Gyawali CP. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring. Aliment Pharmacol Ther. 2012;35(9):1080-7.
-199. Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the “sensitive oesophagus” [Internet]. Gut. 1997;40:587-90. Disponible en: http://dx.doi.org/10.1136/gut.40.5.587
-200. Taghavi SA, Ghasedi M, Saberi-Firoozi M, Alizadeh-Naeeni M, Bagheri-Lankarani K, Kaviani MJ, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut. 2005;54(8):1067-71.
-201. Aanen MC, Weusten BLAM, Numans ME, de Wit NJ, Samsom M, Smout AJPM. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. J Clin Gastroenterol. 2008;42(5):441-7.
-202. Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the“ sensitive oesophagus.” Gut.1997;40(5):587-90.
-203. Diaz S, Aymerich R, Clouse RE, Freedland KE, Prakash C, Soper NJ. The symptom association probability (SAP) is superior to the symptom index (SI) for attributing symptoms to gastroesophageal reflux: validation using outcome from laparoscopic antireflux surgery (LARS). In: Gastroenterology. WB SAUNDERS CO INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA; 2002:A75-A75.
-204. Choksi Y, Slaughter JC, Sharda R, Higginbotham T, Lal P, Vaezi MF. Symptom association probability does not reliably distinguish functional heartburn from reflux hypersensitivity. Aliment Pharmacol Ther. 2018;47(7):958-65.
-205. Marabotto E, Furnari M, Giannini EG, Savarino V, Savarino E. Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn [Internet]. Alimentary Pharmacology & Therapeutics. 2018;48:107-8. Disponible en: http://dx.doi.org/10.1111/apt.14800
-206. Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo H, et al. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn [Internet]. New England Journal of Medicine. 2019;381:1513-23. Disponible en: http://dx.doi.org/10.1056/nejmoa1811424
-207. Hersh MJ, Sayuk GS, Gyawali CP. Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. J Clin Gastroenterol. 2010;44(4):254-60.
-208. Kavitt RT, Higginbotham T, Slaughter JC, Patel D, Yuksel ES, Lominadze Z, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107(12):1826-32.
-209. Rosen R, Amirault J, Heinz N, Litman H, Khatwa U. The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing. Neurogastroenterol Motil. 2014;26(11):1635-41.
-210. Xiao Y, Carson D, Boris L, Mabary J, Lin Z, Nicodème F, et al. The acoustic cough monitoring and manometric profile of cough and throat clearing. Dis Esophagus. 2014;27(1):5-12.
-211. Lechien JR, Akst LM, Hamdan AL, Schindler A, Karkos PD, Barillari MR, et al. Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review [Internet]. Otolaryngology-Head and Neck Surgery. 2019;160:762-82. Disponible en: http://dx.doi.org/10.1177/0194599819827488
-212. Koufman JA. The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation
of 225 Patients Using Ambulatory 24-Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal [Internet]. The Laryngoscope. 1991;101:1-78. Disponible en: http://dx.doi.org/10.1002/lary.1991.101.s53.1
-213. Groome M, Cotton JP, Borland M, McLeod S, Johnston DA, Dillon JF. Prevalence of Laryngopharyngeal Reflux in a Population with Gastroesophageal Reflux [Internet]. The Laryngoscope. 2007;117:1424-8. Disponible en: http://dx.doi.org/10.1097/mlg.0b013e31806865cf
-214. Li Y, Xu G, Zhou B, Tang Y, Liu X, Wu Y, et al. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets [Internet]. European Archives of Oto-Rhino-Laryngology. 2021. Disponible en: http://dx.doi.org/10.1007/s00405-021-07201-w
-215. Du X, Wang F, Hu Z, Wu J, Wang Z, Yan C, et al. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China [Internet]. BMC Gastroenterology. 2017;17. Disponible en: http://dx.doi.org/10.1186/s12876-017-0667-9
-216. Guo Z, Wu Y, Chen J, Zhang S, Zhang C. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring [Internet]. Medical Science Monitor. 2020;16. Disponible en: http://dx.doi.org/10.12659/msm.927381
-217. Hayat JO, Gabieta-Somnez S, Yazaki E, Kang JY, Woodcock A, Dettmar P, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease [Internet]. Gut. 2015;64:373-80. Disponible en: http://dx.doi.org/10.1136/gutjnl-2014-307049
-218. Kim TH, Lee KJ, Yeo M, Kim DK, Cho SW. Pepsin Detection in the Sputum/Saliva for the Diagnosis of Gastroesophageal Reflux Disease in Patients with Clinically Suspected Atypical Gastroesophageal Reflux Disease Symptoms [Internet]. Digestion. 2008;77:201-6. Disponible en: http://dx.doi.org/10.1159/000143795
-219. Matsumura T, Arai M, Suzuki T, Hoppo T, Seki Y, Kasamatsu S, et al. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study [Internet]. Esophagus. 2020;17:339-47. Disponible en: http://dx.doi. org/10.1007/s10388-020-00714-z
-220. Saritas Yuksel E, Hong SKS, Strugala V, Slaughter JC, Goutte M, Garrett CG, et al. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Laryngoscope. 2012;122(6):1312-6.
-221. Weitzendorfer M, Antoniou SA, Schredl P, Witzel K, Weitzendorfer IC, Majerus A, et al. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux [Internet]. The Laryngoscope. 2020;130:1780-6. Disponible en: http://dx.doi.org/10.1002/lary.28320
-222. Dogru M, Kuran G, Haytoglu S, Dengiz R, Arikan OK. Role of Laryngopharyngeal Reflux in the Pathogenesis of Otitis Media with Effusion [Internet]. The Journal of International Advanced Otology. 2015;11:66-71. Disponible en: http://dx.doi.org/10.5152/iao.2015.642
-223. Iannella G, Di Nardo G, Plateroti R, Rossi P, Plateroti AM, Mariani P, et al. Investigation of pepsin in tears of children with laryngopharyngeal reflux disease [Internet]. International Journal of Pediatric Otorhinolaryngology. 2015;79:2312-5. Disponible en: http://dx.doi.org/10.1016/j.ijporl.2015.10.034
-224. Sereg-Bahar M, Jerin A, Jansa R, Stabuc B, Hocevar-Boltezar I. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study [Internet]. Clinical Otolaryngology. 2015;40:234-9. Disponible en: http://dx.doi.org/10.1111/coa.12358
-225. Samuels TL, Johnston N. Pepsin as a Marker of Extraesophageal Reflux [Internet]. Annals of Otology, Rhinology & Laryngology. 2010;119:203-8. Disponible en: http://dx.doi.org/10.1177/000348941011900310
-226. Wang J, Zhao Y, Ren J, Xu Y. Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis. Eur Arch Otorhinolaryngol. 2018;275(3):671-8.
-227. Calvo-Henríquez C, Ruano-Ravina A, Vaamonde P, Martínez-Capoccioni G, Martín-Martín C. Is Pepsin a Reliable Marker of Laryngopharyngeal Reflux? A Systematic Review [Internet]. Otolaryngology-Head and Neck Surgery. 2017;157:385-91. Disponible en: http://dx.doi.org/10.1177/0194599817709430
-228. Merati AL, Lim HJ, Ulualp SO, Toohill RJ. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2005;114(3):177-82.
-229. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92(5):825-9.
-230. Wilhelm D, Jell A, Feussner H, Schmid RM, Bajbouj M, Becker V. Pharyngeal pH monitoring in gastrectomy patients – what do we really measure? [Internet]. United European Gastroenterology Journal. 2016;4:541-5. Disponible en: http://dx.doi.org/10.1177/2050640615617637
-231. Zhong C, Duan L, Wang K, Xu Z, Ge Y, Yang C, et al. Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol. 2013;48(5):601-10.
-232. Kim BS, Park SY, Lee DH, Cho EA, Jun CH, Park CH, et al. Utility of baseline impedance level measurement in patients with gastroesophageal reflux symptoms [Internet]. Scandinavian Journal of Gastroenterology. 2016;51:1-7. Disponible en: http://dx.doi.org/10.3109/00365521.2015.1042031
-233. Mittal RK, Balaban DH. The Esophagogastric Junction [Internet]. New England Journal of Medicine. 1997;336:924-32. Disponible en: http://dx.doi.org/10.1056/nejm199703273361306
-234. Kwiatek MA, Pandolfino JE, Kahrilas PJ. 3D-high resolution manometry of the esophagogastric junction [Internet]. Neurogastroenterology & Motility. 2011;23:e461-9. Disponible en: http://dx.doi.org/10.1111/j.1365-2982.2011.01733.x
-235. Murray JA, Clouse RE, Conklin JL. Components of the standard oesophageal manometry [Internet]. Neurogastroenterology and Motility. 2003;15:591-606. Disponible en: http://dx.doi.org/10.1046/j.1365-2982.2003.00446.x
-236. Savarino E, Giacchino M, Savarino V. Dysmotility and reflux disease [Internet]. Current Opinion in Otolaryngology & Head and Neck Surgery. 2013:11. Disponible en: http://dx.doi.org/10.1097/moo.0b013e3283658edf
-237. Fox MR, Bredenoord AJ. Oesophageal high-resolution manometry: moving from research into clinical practice [Internet]. Gut. 2008;57:405-23. Disponible en: http://dx.doi.org/10.1136/gut.2007.127993
-238. Blonski W, Vela M, Safder A, Hila A, Castell DO. Revised Criterion for Diagnosis of Ineffective Esophageal Motility Is Associated with More Frequent Dysphagia and Greater Bolus Transit Abnormalities [Internet]. The American Journal of Gastroenterology. 2008;103:699-704. Disponible en: http://dx.doi.org/10.1111/j.1572-0241.2007.01593.x
-239. Ho SC, Chang CS, Wu CY, Chen GH. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47(3):652-6.
-240. Shetler KP, Bikhtii S, Triadafilopoulos G. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure [Internet]. Diseases of the Esophagus. 2017;30:1-8. Disponible en: http://dx.doi.org/10.1093/dote/dox012
-241. Kasamatsu S, Matsumura T, Ohta Y, Hamanaka S, Ishigami H, Taida T, et al. The Effect of Ineffective Esophageal Motility on Gastroesophageal Reflux Disease. Digestion. 2017;95(3):221-8.
-242. Liu L, Li S, Zhu K, Yu W, Wang H, Guo J, et al. Relationship between esophageal motility and severity of gastroesophageal reflux disease according to the Los Angeles classification. Medicine. 2019;98(19):e15543.
-243. Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia [Internet]. Best Practice & Research Clinical Gastroenterology. 2008;601-16. Disponible en: http://dx.doi.org/10.1016/j.bpg.2007.12.007
-244. Rengarajan A, Bolkhir A, Gor P, Wang D, Munigala S, Gyawali CP. Esophagogastric junction and esophageal body contraction metrics on high-resolution manometry predict esophageal acid burden. Neurogastroenterol Motil. 2018;30(5):e13267.
-245. van Hoeij FB, Smout AJ, Bredenoord AJ. Predictive value of routine esophageal high-resolution manometry for gastro-esophageal reflux disease. Neurogastroenterol Motil. 2015;27(7):963-70.
-246. Wang F, Li P, Ji GZ, Miao L, Fan Z, You S, et al. An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring. Medicine. 2017;96(5):e5906.
-247. Ribolsi M, Savarino E, Rogers B, Rengarajan A, Della Coletta M, Ghisa M, et al. High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy [Internet]. Journal of Neurogastroenterology and Motility. 2020;26:447-54. Disponible en: http://dx.doi.org/10.5056/jnm19153
-248. Delshad SD, Almario CV, Chey WD, Spiegel BMR. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms [Internet]. Gastroenterology. 2020;158:1250–61.e2. Disponible en: http://dx.doi.org/10.1053/j.gastro.2019.12.014
-249. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55(10):1398-402.
-250. Karamanolis G, Kotsalidis G, Triantafyllou K, Polymeros D, Gaglia A, Fessatou S, et al. Yield of combined impedance-pH monitoring for refractory reflux symptoms in clinical practice. J Neurogastroenterol Motil. 2011;17(2):158-63.
-251. Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009l;7(7):743-8.
-252. Abe Y, Koike T, Saito M, Okata T, Nakagawa K, Hatta W, et al. The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease [Internet]. Digestion. 2021;102:480-8. Disponible en: http://dx.doi.org/10.1159/000506152
-253. Frazzoni M, Conigliaro R, Mirante VG, Melotti G. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn [Internet]. Neurogastroenterology & Motility. 2012;24:141-e87. Disponible en: http://dx.doi.org/10.1111/j.1365-2982.2011.01800.x
-254. Frazzoni M, Piccoli M, Conigliaro R, Manta R, Frazzoni L, Melotti G. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc. 2013;27(8):2940-6.
-255. Bredenoord AJ, Weusten BLAM, Timmer R, Conchillo JM, Smout AJPM. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006;101(3):453-9.
-256. Nakagawa K, Sawada A, Hoshikawa Y, Nikaki K, Sonmez S, Woodland P, et al. Persistent Postprandial Regurgitation vs. Rumination in Patients with Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring [Internet]. American Journal of Gastroenterology. 2019;114:1248-55. Disponible en: http://dx.doi.org/10.14309/ajg.0000000000000295
-257. Halland M, Pandolfino J, Barba E. Diagnosis and Treatment of Rumination Syndrome [Internet]. Clinical Gastroenterology and Hepatology. 2018;16:1549-55. Disponible en: http://dx.doi.org/10.1016/j.cgh.2018.05.049
-258. Saleh CMG, Bredenoord AJ. Utilization of Esophageal Function Testing for the Diagnosis of the Rumination Syndrome and Belching Disorders [Internet]. Gastrointestinal Endoscopy Clinics of North America. 2014;24:633-42. Disponible en: http://dx.doi.org/10.1016/j.giec.2014.06.002
-259. Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders [Internet]. Gastroenterology. 2016;150:1380-92. Disponible en: http://dx.doi.org/10.1053/j.gastro.2016.02.011
-260. Kessing BF, Bredenoord AJ, Smout AJP. The Pathophysiology, Diagnosis and Treatment of Excessive Belching Symptoms [Internet]. American Journal of Gastroenterology. 2014;109:1196-203. Disponible en: http://dx.doi.org/10.1038/ajg.2014.165
-261. Hemmink GJM, Bredenoord AJ, Weusten BLA, Timmer R, Smout AJP. Supragastric Belching in Patients with Reflux Symptoms [Internet]. The American Journal of Gastroenterology. 2009;104:1992-7. Disponible en: http://dx.doi.org/10.1038/ajg.2009.203
-262. Bredenoord AJ. Management of Belching, Hiccups, and Aerophagia [Internet]. Clinical Gastroenterology and Hepatology. 2013;11:6-12. Disponible en: http://dx.doi.org/10.1016/j.cgh.2012.09.006
-263. Yadlapati R, Tye M, Roman S, Kahrilas PJ, Ritter K, Pandolfino JE. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors [Internet]. Clinical Gastroenterology and Hepatology. 2018;16:211-8.e1. Disponible en: http://dx.doi.org/10.1016/j.cgh.2017.09.011
-264. Glasinovic E, Wynter E, Arguero J, Ooi J, Nakagawa K, Yazaki E, et al. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux [Internet]. American Journal of Gastroenterology. 2018;113:539-47. Disponible en: http://dx.doi.org/10.1038/ajg.2018.15
-265. Sawada A, Fujiwara Y, Sifrim D. Belching in Gastroesophageal Reflux Disease: Literature Review [Internet]. Journal of Clinical Medicine. 2020;9:3360. Disponible en: http://dx.doi.org/10.3390/jcm9103360
-266. Narayani RI, Burton MP, Young GS. Utility of esophageal biopsy in the diagnosis of nonerosive reflux disease. Dis Esophagus. 2003;16(3):187-92.
-267. Schindlbeck NE, Wiebecke B, Klauser AG, Voderholzer WA, Müller-Lissner SA. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut. 1996;39(2):151-4.
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Jorge A Olmos, John E Pandolfino, María M Piskorz, Natalia Zamora, Miguel A Valdovinos Díaz, José M Remes Troche, Mauricio Guzmán, Albis Hani, Luis R Valdovinos García, Hannah Pitanga Lukashok, Gerson Domingues, Eduardo Vesco, Mariel Mejia Rivas, Luis F Pineda Ovalle, Daniel Cisternas, Marcelo Vela
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
